David Nolan

HLA-B*5701 Screening for Hypersensitivity to Abacavir

S. Mallal, Elizabeth J. Phillips, Giampiero Carosi et al. · New England Journal of Medicine · 2008 · 1.8K citations · Full text

Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

S. Mallal, David Nolan, Campbell S. Witt et al. · The Lancet · 2002 · 1.4K citations

Allergy, Human Retrovirus, Immunology +7

Predisposition to abacavir hypersensitivity conferred by<i>HLA-B</i>*<i>5701</i>and a haplotypic<i>Hsp70-Hom</i>variant

A. Martin, David Nolan, Silvana Gaudieri et al. · Proceedings of the National Academy of Sciences · 2004 · 442 citations · Full text

Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity

Diana Chessman, Lyudmila Kostenko, Tessa Lethborg et al. · Immunity · 2008 · 331 citations · Full text

Inflammation, Immunogenetic Basis, Autoimmune Disease +12

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts

A. Martin, David Nolan, Ian James et al. · AIDS · 2004 · 315 citations

Demographic Risk Factors, Immunology, Cd4 T Cell Responses +18